Clinical Perspectives in the Evolving Treatment of Advanced Endometrial Carcinoma: Highlights from SGO 2023

home / oncview / clinical-perspectives-in-the-evolving-treatment-of-advanced-endometrial-carcinoma

David O’Malley, MD, reviews endometrial carcinoma, discussing treatment standards, and emerging data presented at the 2023 SGO (Society of Gynecologic Oncology) Annual Meeting on Women’s Cancer.

EP. 1: Overview of Endometrial Carcinoma

David O'Malley, MD, The Ohio State University Comprehensive Cancer Center

April 10th 2023

David O’Malley, MD, provides a comprehensive overview of endometrial carcinoma and treatment options for patients in this setting.

EP. 2: Molecular Profiling and Risk Stratification in Advanced Endometrial Carcinoma

David O'Malley, MD, The Ohio State University Comprehensive Cancer Center

April 10th 2023

David O’Malley, MD, an expert gynecologic oncologist, details molecular profiling and risk stratification for patients with advanced endometrial carcinoma.

EP. 3: Standard Treatments for Patients with Advanced Endometrial Carcinoma

David O'Malley, MD, The Ohio State University Comprehensive Cancer Center

April 17th 2023

A brief review of the current treatment armamentarium for advanced endometrial carcinoma.

EP. 4: KEYNOTE-775: Updates from SGO 2023

David O'Malley, MD, The Ohio State University Comprehensive Cancer Center

April 17th 2023

An expert gynecologic oncologist reviews recent updates presented at SGO 2023 from the KEYNOTE-775 trial for advanced endometrial carcinoma.

EP. 5: Patient Tolerability with Lenvatinib plus Pembrolizumab

David O'Malley, MD, The Ohio State University Comprehensive Cancer Center

April 25th 2023

David O’Malley, MD, details patient tolerance and associated adverse events with lenvatinib plus pembrolizumab for advanced endometrial carcinoma.